| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of cholangiocyte proliferation | 1.28e-06 | 3 | 14 | 2 | GO:1904055 | |
| GeneOntologyBiologicalProcess | regulation of cholangiocyte proliferation | 1.20e-05 | 8 | 14 | 2 | GO:1904054 | |
| GeneOntologyBiologicalProcess | cholangiocyte proliferation | 1.92e-05 | 10 | 14 | 2 | GO:1990705 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 3.88e-05 | 14 | 14 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 8.07e-05 | 20 | 14 | 2 | GO:2000346 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.07e-04 | 23 | 14 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | negative regulation of neural precursor cell proliferation | 2.51e-04 | 35 | 14 | 2 | GO:2000178 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.97e-04 | 38 | 14 | 2 | GO:2000345 | |
| GeneOntologyBiologicalProcess | positive regulation of substrate adhesion-dependent cell spreading | 4.35e-04 | 46 | 14 | 2 | GO:1900026 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 4.35e-04 | 46 | 14 | 2 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 4.35e-04 | 46 | 14 | 2 | GO:0072574 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 4.94e-04 | 49 | 14 | 2 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of substrate adhesion-dependent cell spreading | 8.95e-04 | 66 | 14 | 2 | GO:1900024 | |
| GeneOntologyCellularComponent | cell-substrate junction | 2.89e-03 | 443 | 14 | 3 | GO:0030055 | |
| GeneOntologyCellularComponent | cell-cell junction | 6.48e-03 | 591 | 14 | 3 | GO:0005911 | |
| HumanPheno | Congenital sensorineural hearing impairment | 7.53e-04 | 58 | 4 | 2 | HP:0008527 | |
| HumanPheno | Congenital hearing loss | 7.53e-04 | 58 | 4 | 2 | HP:0001729 | |
| MousePheno | abnormal circulating chloride level | 1.54e-04 | 156 | 10 | 3 | MP:0003018 | |
| MousePheno | abnormal chloride level | 2.13e-04 | 174 | 10 | 3 | MP:0012007 | |
| Domain | PINCH | 1.56e-06 | 3 | 14 | 2 | IPR017351 | |
| Domain | LIM | 1.71e-05 | 69 | 14 | 3 | PF00412 | |
| Domain | - | 1.78e-05 | 70 | 14 | 3 | 2.10.110.10 | |
| Domain | LIM_DOMAIN_2 | 1.86e-05 | 71 | 14 | 3 | PS50023 | |
| Domain | Znf_LIM | 1.86e-05 | 71 | 14 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.86e-05 | 71 | 14 | 3 | PS00478 | |
| Domain | LIM | 1.86e-05 | 71 | 14 | 3 | SM00132 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 6.89e-05 | 18 | 10 | 2 | M840 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 6.89e-05 | 18 | 10 | 2 | MM15123 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 1.82e-04 | 29 | 10 | 2 | M47627 | |
| Pathway | PID_ILK_PATHWAY | 4.41e-04 | 45 | 10 | 2 | M71 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.16e-03 | 73 | 10 | 2 | MM15126 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 36385586 | ||
| Pubmed | LIM domain proteins Pinch1/2 regulate chondrogenesis and bone mass in mice. | 1.50e-07 | 2 | 14 | 2 | 33083097 | |
| Pubmed | Signaling via PINCH: Functions, binding partners and implications in human diseases. | 1.50e-07 | 2 | 14 | 2 | 27590440 | |
| Pubmed | Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis. | 1.50e-07 | 2 | 14 | 2 | 24058607 | |
| Pubmed | Focal adhesion proteins Pinch1 and Pinch2 regulate bone homeostasis in mice. | 1.50e-07 | 2 | 14 | 2 | 31723057 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 16317048 | ||
| Pubmed | Brief research report: Effects of Pinch deficiency on cartilage homeostasis in adult mice. | 4.51e-07 | 3 | 14 | 2 | 36743414 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 12167643 | ||
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 11331308 | ||
| Pubmed | Dissecting integrin-dependent regulation of neural stem cell proliferation in the adult brain. | 1.50e-06 | 5 | 14 | 2 | 24719101 | |
| Pubmed | PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions. | 2.25e-06 | 6 | 14 | 2 | 12651156 | |
| Pubmed | 4.21e-06 | 8 | 14 | 2 | 23658024 | ||
| Pubmed | 1.37e-05 | 14 | 14 | 2 | 19652092 | ||
| Pubmed | 2.56e-05 | 19 | 14 | 2 | 19349584 | ||
| Pubmed | 9.23e-05 | 225 | 14 | 3 | 25277244 | ||
| Pubmed | CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110). | 2.21e-04 | 55 | 14 | 2 | 23178491 | |
| Pubmed | Antigens recognized by autologous antibody in patients with renal-cell carcinoma. | 2.90e-04 | 63 | 14 | 2 | 10508479 | |
| Cytoband | 17q25.1 | 2.76e-04 | 81 | 14 | 2 | 17q25.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 3.85e-03 | 307 | 14 | 2 | chr17q25 | |
| GeneFamily | LIM zinc finger domain containing|LIM domain containing | 1.65e-06 | 4 | 10 | 2 | 1163 | |
| GeneFamily | LIM domain containing | 4.63e-04 | 59 | 10 | 2 | 1218 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 2.49e-05 | 187 | 14 | 3 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.49e-05 | 187 | 14 | 3 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.53e-05 | 188 | 14 | 3 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-05 | 190 | 14 | 3 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.90e-05 | 197 | 14 | 3 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | IIH-CD4-naive_CD4|IIH / Condition, Cell_class and T cell subcluster | 2.95e-05 | 198 | 14 | 3 | 85414b283bbcdbf3393ab1b4302ef0e21c7a8181 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.95e-05 | 198 | 14 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.99e-05 | 199 | 14 | 3 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Efna5-Inhibitory_Gad1Gad2_Htr3a.Efba5_(Interneuron,__(candidate_CGE-derived_4))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.52e-04 | 59 | 14 | 2 | e85f816cbebe7efe99d368cf5c01e68b39e231ac | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Efna5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.52e-04 | 59 | 14 | 2 | 52cf452beca2fc91f131997610228a1b04a7f5df | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Efna5-Inhibitory_Gad1Gad2_Htr3a.Efba5_(Interneuron,__(candidate_CGE-derived_4))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.52e-04 | 59 | 14 | 2 | 18cb0aaa7c0652721b4004a042cbc8ff4328a065 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.39e-04 | 121 | 14 | 2 | b6dada0712b1f9793bc61e54ec7f10c9eaf53b86 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 6.71e-04 | 124 | 14 | 2 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-dn_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.93e-04 | 126 | 14 | 2 | 13333101d52300fc45fb9f7ca05cace502c72186 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-dn_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.93e-04 | 126 | 14 | 2 | 5d13a2a37efd2645d2859f02e5abb36864896bbe | |
| ToppCell | Control-Lymphoid_T/NK-dn_T|Control / Disease group, lineage and cell class | 7.04e-04 | 127 | 14 | 2 | 58f47cb079c596a9119d8bf158c1681b28360ac3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-dn_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.04e-04 | 127 | 14 | 2 | d4c6e65a4e4c2c9422bea11b9f78e4beabf04961 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-dn_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.04e-04 | 127 | 14 | 2 | 4ccda89414f18313269be2f5a1542314b1b10572 | |
| ToppCell | Control-dn_T|Control / Disease condition and Cell class | 7.15e-04 | 128 | 14 | 2 | e492684b2eafc6c91d2e7d7b9f54defb6642069e | |
| ToppCell | PBMC-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 7.71e-04 | 133 | 14 | 2 | e53fbd69775a4bff61de82557342f7ac80915c4d | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 8.30e-04 | 138 | 14 | 2 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 9.28e-04 | 146 | 14 | 2 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | Mild/Remission-B_naive-5|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.53e-04 | 148 | 14 | 2 | 8b60f9843505660b3c9d5c7792976f902be4b94c | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.53e-04 | 148 | 14 | 2 | 438fe292d29be0206e1d9fd59ede5f8368f13665 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK_CD56bright|Leuk-UTI / Disease, Lineage and Cell Type | 1.07e-03 | 157 | 14 | 2 | db0057741d06e212a9543cb4b011659b79efeafc | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 159 | 14 | 2 | e967b557fe6ae4879d36f62c0297cbf6a2ad1ce9 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 159 | 14 | 2 | 9db971130509c62d439e0cab16588a4d994d7aa0 | |
| ToppCell | T_cells-TFH-like_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.17e-03 | 164 | 14 | 2 | b10cf59f4cc37ca6cd0ecf71d7de278cc2bdd8b5 | |
| ToppCell | Ionocyte|World / shred by cell class for turbinate | 1.18e-03 | 165 | 14 | 2 | 0cb2199b87f17ece743fb2652b2f448dfa78ae0b | |
| ToppCell | COVID-19_Severe-PLT_1|World / Disease Group and Platelet Clusters | 1.20e-03 | 166 | 14 | 2 | 2c89b45eb20e24aae165f1a8e61680d3b63210ac | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type | 1.21e-03 | 167 | 14 | 2 | f4f188a8efca8cdd0ecfb857fe4538c10847eadd | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-03 | 167 | 14 | 2 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 1.22e-03 | 168 | 14 | 2 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.22e-03 | 168 | 14 | 2 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 169 | 14 | 2 | 8dba7546adc6b1345933eec81fc77fc9611fae60 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 169 | 14 | 2 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-03 | 169 | 14 | 2 | df1fc1477bbbb285063b9b122b1ac84c87fd7fa8 | |
| ToppCell | Control-Hematopoietic_Meg-Ery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-03 | 169 | 14 | 2 | c2e2a7b89fe4a64d79efafdec037c4104f433061 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-03 | 169 | 14 | 2 | 92986559aa4a744e8b0487b0ae035cfb1fbf9890 | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-03 | 169 | 14 | 2 | 822e5b6c1e55e196e6d2a38bf183fd220c45703e | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 169 | 14 | 2 | d2862a7ddee6d7a65d84ef9d0800ba6f4690973f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-03 | 170 | 14 | 2 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-03 | 170 | 14 | 2 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | control-dn_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-03 | 170 | 14 | 2 | 839f62860b4a52d06e6a8fce7632195c7310b89d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-03 | 171 | 14 | 2 | 317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736 | |
| ToppCell | Mild-CD4+_T_Exhausted|World / Disease group and Cell class | 1.28e-03 | 172 | 14 | 2 | efe68d9477aa873b1637ee689f298120303aa322 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-03 | 173 | 14 | 2 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.30e-03 | 173 | 14 | 2 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-03 | 173 | 14 | 2 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.30e-03 | 173 | 14 | 2 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-03 | 173 | 14 | 2 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-03 | 173 | 14 | 2 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | Influenza_Severe-B_intermediate|Influenza_Severe / Disease group and Cell class | 1.31e-03 | 174 | 14 | 2 | 4276bdaac53aebd3084323a90ecde572d3177446 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.31e-03 | 174 | 14 | 2 | 7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb | |
| ToppCell | Control-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 1.31e-03 | 174 | 14 | 2 | 522a6d5d9809271c63b85f62ac6ec52a6e3c355e | |
| ToppCell | Mild-CD4+_T_Exhausted|Mild / Disease group and Cell class | 1.33e-03 | 175 | 14 | 2 | 6df099f37875f2cd63502b732a2e07ebfec50e47 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-03 | 175 | 14 | 2 | 4d36da7399c62c170cb603957b35a35efb2c3fbe | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-03 | 175 | 14 | 2 | e4c9b3c6bde390a3892b112b673f93e118220eb9 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.33e-03 | 175 | 14 | 2 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-03 | 175 | 14 | 2 | 2c39c1b112e873403ad2add8595cc256bf0b97a6 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-03 | 176 | 14 | 2 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.34e-03 | 176 | 14 | 2 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-03 | 176 | 14 | 2 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.34e-03 | 176 | 14 | 2 | b794275fdd757b8fa2108e3c867f23da2649146d | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.36e-03 | 177 | 14 | 2 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.36e-03 | 177 | 14 | 2 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-03 | 178 | 14 | 2 | 370749834a11d981e9ede26d5f63f0ecb551c015 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.37e-03 | 178 | 14 | 2 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-03 | 178 | 14 | 2 | eafacc8cd3e986d6ca309e05b6e241331a584fa5 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-03 | 178 | 14 | 2 | 6a5c31e976852edc7d9e899da8e2a1bf23d36759 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-03 | 179 | 14 | 2 | 10c7d371937d9d93c12c8d3465430ef9e0c2ec81 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-03 | 179 | 14 | 2 | 7329b45376a9e9a4fe34d4aa0b33af6dda0a8e3b | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-03 | 179 | 14 | 2 | 6e4740f99f66d3e9348fa5057cf1030454819aa8 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-03 | 179 | 14 | 2 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-03 | 179 | 14 | 2 | ee60ac43fb62c09967a26bbcf9306ac5ea2bdc1e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-03 | 180 | 14 | 2 | 156b988b71f6dcf3117c1e5f4625632cb97e54f2 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-03 | 180 | 14 | 2 | d1beaf1f106c7efaeaf61f29742d0a7310a83916 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-03 | 181 | 14 | 2 | 0756d7d315b8cdd07a3cf6cdfc8a0679786b8e6a | |
| ToppCell | COVID-19_Severe-PLT_1|COVID-19_Severe / Disease Group and Platelet Clusters | 1.42e-03 | 181 | 14 | 2 | 20f7603ceb89b965570e39ae3e88a6d26ebf5b67 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-03 | 181 | 14 | 2 | 3f0d88e9506d66d4e71b88c50d5187302065930f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-03 | 181 | 14 | 2 | b09947d2d7b21f96d98b87ceb6f467ea329c4092 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-03 | 181 | 14 | 2 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | B_cell_maturation-immature_B_cell|World / Lineage and Cell class | 1.43e-03 | 182 | 14 | 2 | 2c7c51ebc4125d8a33454ffee0b143579ce5e451 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 182 | 14 | 2 | 0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.43e-03 | 182 | 14 | 2 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.47e-03 | 184 | 14 | 2 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.47e-03 | 184 | 14 | 2 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.47e-03 | 184 | 14 | 2 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class | 1.48e-03 | 185 | 14 | 2 | 30f064ab7c3890e6f419a845276b145112e78f52 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-03 | 185 | 14 | 2 | 17542ccd52a821c9e99b1a7469e80502e764b3fd | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.48e-03 | 185 | 14 | 2 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-03 | 185 | 14 | 2 | d685a5a2e525db2eba449cfa1e5cd54eb36162a8 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.48e-03 | 185 | 14 | 2 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-03 | 185 | 14 | 2 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-03 | 185 | 14 | 2 | f3b1907c3b6f930bc161f46efce5e143babab507 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.48e-03 | 185 | 14 | 2 | 44ce50cb99df8ffc50eba311adcf688477618659 | |
| ToppCell | COVID-19_Severe-RBC|World / disease group, cell group and cell class | 1.48e-03 | 185 | 14 | 2 | 96b7058b1b282134970aa9e75285760a9f94a8b5 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.48e-03 | 185 | 14 | 2 | 5d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.48e-03 | 185 | 14 | 2 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R-RBC|COVID-19_Severe / Disease group, lineage and cell class | 1.48e-03 | 185 | 14 | 2 | 3ed6090b822c6d1d400a421236cddc7511743932 | |
| Disease | common carotid intimal medial thickness | 4.54e-04 | 67 | 14 | 2 | EFO_0004860 | |
| Disease | Nonsyndromic Deafness | 6.63e-04 | 81 | 14 | 2 | C3711374 | |
| Disease | mitochondrial DNA measurement | 1.03e-02 | 328 | 14 | 2 | EFO_0006312 | |
| Disease | grip strength measurement | 1.16e-02 | 350 | 14 | 2 | EFO_0006941 | |
| Disease | reticulocyte measurement | 1.23e-02 | 1053 | 14 | 3 | EFO_0010700 | |
| Disease | comparative body size at age 10, self-reported | 1.64e-02 | 420 | 14 | 2 | EFO_0009819 | |
| Disease | C-reactive protein measurement | 1.77e-02 | 1206 | 14 | 3 | EFO_0004458 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEQDFRKYEEGFDPY | 426 | Q9Y6N9 | |
| PFRDIFYYEDDSEGE | 861 | Q15361 | |
| GGREGKFYRELEDYF | 946 | Q8TBY9 | |
| EDYDDDRDDPKYYRG | 501 | P49756 | |
| PEFENGLEKDFYGYQ | 551 | Q7RTS5 | |
| PEGLFYEFEGRKYCE | 51 | Q7Z4I7 | |
| EYTEDYEQPRGKGSF | 156 | Q86VF7 | |
| YYGRSVDFRDPFEKE | 811 | Q7Z6E9 | |
| GYRKGAPAEEAEFYD | 376 | Q8NBE8 | |
| NFSEFYEENYEGGKE | 1066 | O60503 | |
| PEGLFYEFEGRKYCE | 46 | P48059 | |
| SDEYEEDGFCQPYRG | 161 | Q01973 | |
| RYIEDPGFGYEDFAR | 326 | P58005 | |
| EPYYNEAGFDSDRGL | 1076 | Q9C0C9 |